Kelly Kenzik Answers: Do Racial Survival Disparities Persist Long-Term?
Kelly Kenzik, MS, PhD, epidemiologist at the University of Alabama at Birmingham School of Medicine, discusses her findings regarding long-term mortality disparities among African American and white women with breast cancer.
Kelly Kenzik, MS, PhD, epidemiologist at the University of Alabama at Birmingham School of Medicine, discusses her findings regarding long-term mortality disparities among African American and white women with breast cancer.
Previous literature mentions that more black women die of breast cancer than white women in the immediate stage after diagnosis, but Kenzik wanted to see if the difference was sustained 5 to 7 years post-diagnosis. She found that the disparity does persist, but not for all causes of death. When she controlled for pre-cancer conditions, like cardiovascular disease, or secondary cancers, the inequality disappears. However, more African American women were dying from the primary cancer than Caucasian women.
Olaparib Plus Chemo May Not Improve Outcomes vs Chemo Alone in BRCA Wild-Type TNBC
April 23rd 2024Patients with BRCA wild-type triple-negative breast cancer treated with olaparib on a gap schedule with chemotherapy did not experience improved responses compared with chemotherapy alone in the neoadjuvant setting.
FDA Grants Accelerated Approval to Fam-Trastuzumab Deruxtecan-Nxki in HER2+ Solid Tumors
April 5th 2024The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu) for patients with unresectable or metastatic HER2-positive solid tumors who have received prior systemic treatment.
